Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Obamacare Made Drug Benefits Worthless

Posted on May 24, 2022 by Devon Herrick

Obamacare mandated health plans have drug coverage. That drug coverage is basically worthless because high-deductibles and coinsurance (i.e. cost-sharing) ensures that most enrollees are paying for all of their prescription drugs out of pocket. Drug plans under Obamacare plans usually have tiered formularies and drug copays that vary based on the drug. When picking up a prescription it is often cheaper to whip out a drug discount card and pay cash than to whip out your health plan ID card and pay a copay.

+

Open Borders and Lax Drug Policies Are Contributing to Fatal Drug Overdoses

Posted on May 19, 2022 by John C. Goodman

Most of the additional fatal overdoses post-Covid involve methamphetamine and fentanyl made in Mexico, China and India. For each overdose death, more than 100 people struggle with debilitating addictions to these dangerous substances.

Coincident with policy changes advertised as civil-rights progress, the comparatively low drug-overdose rate for blacks began to accelerate. It reached the white rate by 2019 and then surged past it during the pandemic to reach 43 annually per 100,000 of the black population by last September.

Joe Grogan and Casey Mulligan in the WSJ.

+

Lowering Eligibility to Age 60 will Bankrupt Medicare Sooner

Posted on May 18, 2022May 18, 2022 by Devon Herrick

The Congressional Budget Office (CBO) released a new report on lowering the age for Medicare eligibility to age 60. The report Budgetary Effects of a Policy That Would Lower the Age of Eligibility for Medicare to 60 found Medicare rolls would rise by nearly 14 million people. It would also increase the budget deficit by $155 billion over a 5-year period.

+

Wednesday Links

Posted on May 18, 2022July 25, 2022 by John C. Goodman

Right to try: The main obstacle is not government; it’s the drug companies.

Covid fact: For people under 25, Covid was less deadly than traffic accidents.

Additional fact: the Asian death rate was about half the white rate, one-third the black rate, and one-fourth the Hispanic rate.  (Rough estimates)

Why is the Covid death rate in Australia one-tenth of the U.S. level?

David Henderson: The FDA should approve the Alzheimer drug Aduhelm, but Medicare shouldn’t pay for it.

+
  • Previous
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • …
  • 187
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom